Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain
Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
A novel approach to the symptomatic treatment of autism
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders
Targeting the endocannabinoid system in the treatment of fragile X syndrome
